mTORC1 inhibitor RAD001 (everolimus) enhances non-small cell lung cancer cell radiosensitivity in vitro via suppressing epithelial–mesenchymal transition

mTORC1 inhibitor RAD001 (everolimus) enhances non-small cell lung cancer cell radiosensitivity in vitro via suppressing epithelial–mesenchymal transitionmTORC1 inhibitor RAD001 (everolimus) enhances non-small cell lung cancer cell radiosensitivity in vitro via suppressing epithelial–mesenchymal transition, Published online: 22 February 2019; doi:10.1038/s41401-019-0215-ymTORC1 inhibitor RAD001 (everolimus) enhances non-small cell lung cancer cell radiosensitivity in vitro via suppressing epithelial–mesenchymal transition

http://feeds.nature.com/~r/aps/rss/current/~3/gD8tLXO0vI0/s41401-019-0215-y

Source: Acta Pharmacologica Sinica - February 22, 2019 Category: Drugs & Pharmacology Authors: Yu Chen Wen-wen LI Ping Peng Wei-heng Zhao Yi-jun Tian Yu Huang Shu Xia Yuan Chen Source Type: research

More News: Cancer | Cancer & Oncology | Drugs & Pharmacology | Lung Cancer | Non-Small Cell Lung Cancer